Histone deacetylase inhibitor‐mediated cell death is distinct from its global effect on chromatin
Victoria Luchenko(Center for Cancer Research), Susan E. Bates(New York Oncology Hematology)
Cited by 49
Related Papers
From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance
|Cellular and Molecular Life Sciences|2001|685
Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
|Drug Metabolism and Disposition|2010|216
R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin
|Molecular Cancer Research|2021|30